The Enterprise Value as of December 2025 (TTM) for NRx Pharmaceuticals, Inc. (NRXP) is 35.34M

According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.34M. This represents a change of -28.27% compared to the average of 49.27M of the last 4 quarters.

NRx Pharmaceuticals, Inc. (NRXP) Historical Enterprise Value (quarterly & annually)

How has NRXP Enterprise Value performed in the past?

The mean historical Enterprise Value of NRx Pharmaceuticals, Inc. over the last ten years is 421.34M. The current 35.34M Enterprise Value has changed 738.76% with respect to the historical average. Over the past ten years (40 quarters), NRXP's Enterprise Value was at its highest in in the September 2021 quarter at 5.04B. The Enterprise Value was at its lowest in in the September 2017 quarter at 17.53K.

NRx Pharmaceuticals, Inc. (NRXP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NRx Pharmaceuticals, Inc. (NRXP) Average Enterprise Value

How has NRXP Enterprise Value performed in the past?

The current Enterprise Value of NRx Pharmaceuticals, Inc. (NRXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NRx Pharmaceuticals, Inc. (NRXP) Enterprise Value vs. Peers

How is NRXP’s Enterprise Value compared to its peers?

NRx Pharmaceuticals, Inc.’s Enterprise Value is greater than Cue Biopharma, Inc. (23.68M), less than Outlook Therapeutics, Inc. (117.30M), less than Spruce Biosciences, Inc. (37.92M), less than Coeptis Therapeutics, Inc. (52.89M), greater than Werewolf Therapeutics, Inc. (-8613546.00), greater than Equillium, Inc. (-1382527.00), less than Karyopharm Therapeutics Inc. (112.81M), greater than IO Biotech, Inc. (19.58M), less than Century Therapeutics, Inc. (39.85M), less than Senti Biosciences, Inc. (76.24M),

Build a custom stock screener for NRx Pharmaceuticals, Inc. (NRXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NRx Pharmaceuticals, Inc. (NRXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.